A detailed history of Jpmorgan Chase & CO transactions in Optimize Rx Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 7,783 shares of OPRX stock, worth $34,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,783
Previous 112,533 93.08%
Holding current value
$34,400
Previous $1.13 Million 94.67%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$7.2 - $11.23 $754,200 - $1.18 Million
-104,750 Reduced 93.08%
7,783 $60,000
Q2 2024

Aug 12, 2024

SELL
$8.8 - $13.17 $233,332 - $349,202
-26,515 Reduced 19.07%
112,533 $1.13 Million
Q1 2024

May 10, 2024

BUY
$11.47 - $16.17 $139,383 - $196,497
12,152 Added 9.58%
139,048 $1.69 Million
Q4 2023

Feb 12, 2024

BUY
$7.06 - $14.49 $14,070 - $28,878
1,993 Added 1.6%
126,896 $1.82 Million
Q3 2023

Nov 14, 2023

SELL
$7.43 - $14.96 $71,476 - $143,915
-9,620 Reduced 7.15%
124,903 $971,000
Q2 2023

Aug 11, 2023

SELL
$11.63 - $15.63 $75,071 - $100,891
-6,455 Reduced 4.58%
134,523 $1.92 Million
Q1 2023

May 18, 2023

BUY
$12.54 - $19.38 $160,524 - $248,083
12,801 Added 9.99%
140,978 $2.06 Million
Q1 2023

May 11, 2023

SELL
$12.54 - $19.38 $187,071 - $289,110
-14,918 Reduced 10.43%
128,177 $1.88 Million
Q4 2022

Feb 13, 2023

BUY
$13.77 - $22.04 $1.84 Million - $2.94 Million
133,358 Added 1369.6%
143,095 $2.4 Million
Q3 2022

Nov 14, 2022

BUY
$13.74 - $30.13 $2,857 - $6,267
208 Added 2.18%
9,737 $144,000
Q2 2022

Aug 11, 2022

SELL
$21.94 - $40.49 $81,309 - $150,055
-3,706 Reduced 28.0%
9,529 $261,000
Q1 2022

May 11, 2022

BUY
$35.27 - $62.91 $67,718 - $120,787
1,920 Added 16.97%
13,235 $499,000
Q4 2021

Feb 10, 2022

BUY
$53.57 - $98.0 $257,564 - $471,184
4,808 Added 73.89%
11,315 $702,000
Q3 2021

Nov 12, 2021

BUY
$50.93 - $85.55 $331,401 - $556,673
6,507 New
6,507 $556,000

Others Institutions Holding OPRX

About OptimizeRx Corp


  • Ticker OPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 18,023,100
  • Market Cap $79.7M
  • Description
  • OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...
More about OPRX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.